VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Approved
DIN Number
02452561
Drug Class
Human
Market Date
N/A
Company
HC
VPI Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02452561
AIG Number0225919006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.16.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
PIPERACILLIN (PIPERACILLIN SODIUM)Active
Strength: 4 G / VIAL
Monograph: PIPERACILLIN (PIPERACILLIN SODIUM)
TAZOBACTAM (TAZOBACTAM SODIUM)Active
Strength: 0.5 G / VIAL
Monograph: TAZOBACTAM (TAZOBACTAM SODIUM)